Validation of ClarityDX Prostate as a Reflex Test to Refine the Prediction of Clinically-significant Prostate Cancer

Clinical trial NCT03957252 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT03957252
Sponsor: Nanostics
Status: ACTIVE_NOT_RECRUITING
Study type: OBSERVATIONAL

Prostate Cancer Prostate Cancer Screening Performance Assessment of Novel Test

Start date: 2019-06-06
Primary completion: 2027-03-01
Enrollment: 2800

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.